- Home
- POET vs LXRX Comparison
POET vs LXRX Comparison
Compare POET & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POET
- LXRX
- Stock Information
- Founded
- POET 1972
- LXRX 1995
- Country
- POET Canada
- LXRX United States
- Employees
- POET N/A
- LXRX N/A
- Industry
- POET Semiconductors
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- POET Technology
- LXRX Health Care
- Exchange
- POET Nasdaq
- LXRX Nasdaq
- Market Cap
- POET 450.6M
- LXRX 392.2M
- IPO Year
- POET N/A
- LXRX 2000
- Fundamental
- Price
- POET $6.23
- LXRX $1.10
- Analyst Decision
- POET Strong Buy
- LXRX Buy
- Analyst Count
- POET 2
- LXRX 4
- Target Price
- POET $6.25
- LXRX $3.67
- AVG Volume (30 Days)
- POET 3.4M
- LXRX 4.7M
- Earning Date
- POET 08-13-2025
- LXRX 08-06-2025
- Dividend Yield
- POET N/A
- LXRX N/A
- EPS Growth
- POET N/A
- LXRX N/A
- EPS
- POET N/A
- LXRX N/A
- Revenue
- POET $199,477.00
- LXRX $31,213,000.00
- Revenue This Year
- POET $8,377.56
- LXRX N/A
- Revenue Next Year
- POET $1,061.73
- LXRX N/A
- P/E Ratio
- POET N/A
- LXRX N/A
- Revenue Growth
- POET N/A
- LXRX 1251.21
- 52 Week Low
- POET $2.27
- LXRX $0.28
- 52 Week High
- POET $7.79
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- POET 54.73
- LXRX 54.72
- Support Level
- POET $5.94
- LXRX $1.16
- Resistance Level
- POET $6.95
- LXRX $1.26
- Average True Range (ATR)
- POET 0.59
- LXRX 0.11
- MACD
- POET -0.09
- LXRX -0.01
- Stochastic Oscillator
- POET 45.02
- LXRX 42.11
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.